PPIPT01102
Target Protein Information
| Protein_Name | Lupus La protein |
|---|---|
| Protein_Sequence | MAENGDNEKMAALEAKICHQIEYYFGDFNLPRDKFLKEQIKLDEGWVPLEIMIKFNRLNRLTTDFNVIVEALSKSKAELMEISEDKTKIRRSPSKPLPEVTDEYKNDVKNRSVYIKGFPTDATLDDIKEWLEDKGQVLNIQMRRTLHKAFKGSIFVVFDSIESAKKFVETPGQKYKETDLLILFKDDYFAKKNEERKQNKVEAKLRAKQEQEAKQKLEEDAEMKSLEEKIGCLLKFSGDLDDQTCREDLHILFSNHGEIKWIDFVRGAKEGIILFKEKAKEALGKAKDANNGNLQLRNKEVTWEVLEGEVEKEALKKIIEDQQESLNKWKSKGRRFKGKGKGNKAAQPGSGKGKVQFQGKKTKFASDDEHDEHDENGATGPVKRAREETDKEEPASKQQKTENGAGDQ |
| Organism_Source | Homo sapiens |
| Functional_Classification | RNA-binding protein (La antigen) |
| Cellular_Localization | Cytoplasm |
| Gene_Names | SSB |
| UniProt_ID | P05455 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | LaR2C-N7 |
|---|---|
| Peptide_Sequence | KYKETDL |
| Peptide_Length | 7 |
| Peptide_SMILES | CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 896.01 |
|---|---|
| Aliphatic_Index | 55.71429 |
| Aromaticity | 0.14286 |
| Average_Rotatable_Bonds | 4.42857 |
| Charge_at_pH_7 | -0.00123 |
| Isoelectric_point | 6.48621 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 14 |
| Number_of_Hydrogen_Bond_Donors | 14 |
| Topological_Polar_Surface_Area | 405.02000 |
| X_logP_energy | -2.72020 |
Interaction Information
| Affinity | IC50=40 uM |
|---|---|
| Affinity_Assay | in vitro translation assay |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | SMALLANTIVIRAL PEPTIDES AGAINST HEPATITIS CVIRUS |
| Release_Year | 2009 |
| Patent_ID | US20090233868A1 |